Pratico D - Search Results

1

8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo.

Delanty N, Reilly M, Pratico D, FitzGerald DJ, Lawson JA, FitzGerald GA. Delanty N, et al. Among authors: pratico d. Br J Clin Pharmacol. 1996 Jul;42(1):15-9. doi: 10.1046/j.1365-2125.1996.03804.x. Br J Clin Pharmacol. 1996. PMID: 8807139 Free PMC article. Review.

2

Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.

Praticò D, Smyth EM, Violi F, FitzGerald GA. Praticò D, et al. J Biol Chem. 1996 Jun 21;271(25):14916-24. doi: 10.1074/jbc.271.25.14916. J Biol Chem. 1996. PMID: 8663015 Free article.

3

Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes.

Praticò D, Reilly M, Lawson JA, FitzGerald GA. Praticò D, et al. Agents Actions Suppl. 1997;48:25-41. doi: 10.1007/978-3-0348-7352-9_2. Agents Actions Suppl. 1997. PMID: 9177098 Review.

4

8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.

Delanty N, Reilly MP, Pratico D, Lawson JA, McCarthy JF, Wood AE, Ohnishi ST, Fitzgerald DJ, FitzGerald GA. Delanty N, et al. Among authors: pratico d. Circulation. 1997 Jun 3;95(11):2492-9. doi: 10.1161/01.cir.95.11.2492. Circulation. 1997. PMID: 9184579

5

Localization of distinct F2-isoprostanes in human atherosclerotic lesions.

Praticò D, Iuliano L, Mauriello A, Spagnoli L, Lawson JA, Rokach J, Maclouf J, Violi F, FitzGerald GA. Praticò D, et al. J Clin Invest. 1997 Oct 15;100(8):2028-34. doi: 10.1172/JCI119735. J Clin Invest. 1997. PMID: 9329967 Free PMC article.

6

IPF2alpha-I: an index of lipid peroxidation in humans.

Praticò D, Barry OP, Lawson JA, Adiyaman M, Hwang SW, Khanapure SP, Iuliano L, Rokach J, FitzGerald GA. Praticò D, et al. Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3449-54. doi: 10.1073/pnas.95.7.3449. Proc Natl Acad Sci U S A. 1998. PMID: 9520386 Free PMC article.

7

Cellular activation by thromboxane A2 and 8-EPI-PGF2 alpha.

Pratico D, O'Mahony D, Lawson J, Kinsella T, Fitzgerald GA. Pratico D, et al. Adv Exp Med Biol. 1997;400A:229-33. Adv Exp Med Biol. 1997. PMID: 9547562 No abstract available.

8

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

Praticò D, Basili S, Vieri M, Cordova C, Violi F, Fitzgerald GA. Praticò D, et al. Am J Respir Crit Care Med. 1998 Dec;158(6):1709-14. doi: 10.1164/ajrccm.158.6.9709066. Am J Respir Crit Care Med. 1998. PMID: 9847257

9

Increased formation of distinct F2 isoprostanes in hypercholesterolemia.

Reilly MP, Praticò D, Delanty N, DiMinno G, Tremoli E, Rader D, Kapoor S, Rokach J, Lawson J, FitzGerald GA. Reilly MP, et al. Among authors: pratico d. Circulation. 1998 Dec 22-29;98(25):2822-8. doi: 10.1161/01.cir.98.25.2822. Circulation. 1998. PMID: 9860782

10

The isoprostanes in biology and medicine.

Praticò D, Lawson JA, Rokach J, FitzGerald GA. Praticò D, et al. Trends Endocrinol Metab. 2001 Aug;12(6):243-7. doi: 10.1016/s1043-2760(01)00411-8. Trends Endocrinol Metab. 2001. PMID: 11445440 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

309 results

Search Page